Financial Reports
Related Searches:
Filter by:
February 7, 2008
Millennium
4Q Revenues: $181.2 million (+30%)
4Q Earnings: $41.0 million (earnings were $8.3 million in 4Q2006)
FY Revenues: $527.5 million (+8%)
FY Earnings: $14.9 million (loss of $44.0 million FY2006)
Comments: U.S. sales of…
Read More »
February 6, 2008
Biogen Idec
4Q Revenues: $893 million (+26%)
4Q Earnings: $201 million (+84%)
FY Revenues: $3.2 billion (+18%)
FY Earnings: $638 million (+193%)
Comments: FY07 growth was primarily driven by Tysabri, Rituxan and Avonex sales. Through t…
Read More »
January 31, 2008
Wyeth
4Q Revenues: $5.8 billion (+10%)
4Q Earnings: $1.0 billion (+19%)
FY Revenues: $22.4 billion (+10%)
FY Earnings: $4.6 billion (+10%)
Comments: Worldwide pharmaceutical sales increased 10% in both 4Q07 and FY07 due to higher sales…
Read More »
January 31, 2008
Bristol-Myers Squibb
4Q Revenues: $5.4 billion (+33%)
4Q Loss: $89 million (loss of $134 million in 4Q2006)
FY Revenues: $19.3 billion (+12%)
FY Earnings: $2.2 billion (+37%)
Comments: Worldwide pharmaceutical sales increased 39%…
Read More »
January 30, 2008
Roche
FY Revenues: $42.2 billion (+10%)
FY Earnings: $8.9 billion (+25%)
Comments: Pharmaceutical sales were up 10% to $32.7 billion. Earnings growth was driven by sales of cancer drugs, MabThera (+15%) to $4.9 billion, as well as Herceptin…
Read More »
January 30, 2008
Merck 4Q07
4Q Revenues: $6.2 billion (+3%)
4Q Loss: $1.6 billion (earnings were $473.9 million in 4Q06)
FY Revenues: $24.2 billion (+7%)
FY Earnings: $3.3 billion (-26%)
Comments: 4Q Singulair sales were up 20% to $1.2 billion and FY s…
Read More »
January 29, 2008
Lilly
4Q Revenues: $5.2 billion (+22%)
4Q Earnings: $854.4 million (earnings were $132 million 4Q2006)*
FY Revenues: $18.6 billion (+19%)
FY Earnings: $3.0 billion (+11%)
Comments: Sales of Alimta, Byetta, Cialis, Cymbalta, Forteo, St…
Read More »
January 25, 2008
Amgen
4Q Revenues: $3.7 billion (-2%)
4Q Earnings: $835 million (flat)
FY Revenues: $14.8 billion (+4%)
FY Earnings: $3.2 billion (+7%)
Comments: Worldwide Aranesp sales were down 25% to $827 million in 4Q07, due to a decline in U.S. d…
Read More »
January 24, 2008
Abbott
4Q Revenues: $7.2 billion (+16%)
4Q Earnings: $1.2 billion (loss of $476 million 4Q06)*
FY Revenues: $25.9 billion (+15%)
FY Earnings: $3.6 billion (+110%)
Comments: Worldwide pharmaceutical sales in the quarter were $4.2 billio…
Read More »
January 24, 2008
Gilead Sciences
4Q Revenues: $1.1 billion (+22%)
4Q Earnings: $401.6 million (loss of $1.7 billion in 4Q06)*
FY Revenues: $4.2 billion (+40%)
FY Earnings: $1.6 billion (loss of $1.2 billion FY06)*
Comments: Product sales were a r…
Read More »
January 23, 2008
Pfizer
4Q Revenues: $13.1 billion (+4%)
4Q Earnings: $2.9 billion (-70%)
FY Revenues: $48.6 billion (+1%)
FY Earnings: $8.3 billion (-57%)
Comments: Pharmaceutical revenues for the quarter were $11.9 billion, up 2% thanks to favorable…
Read More »
January 22, 2008
J&J
4Q Revenues: $16.0 billion (+17%)
4Q Earnings: $2.4 billion (+10%)
FY Revenues: $61.1 billion (+15%)
FY Earnings: $10.6 billion (-4%)
Comments: Worldwide pharmaceutical sales were up 7% to $24.9 billion for the year. Sales grow…
Read More »
January 17, 2008
Novartis
4Q Revenues: $9.9 billion (+6%)
4Q Earnings: $931 million (-42%)
YTD Revenues: $39.8 billion (+8%)
YTD Earnings: $12.0 billion (+66%)
Comments: U.S. pharmaceutical sales were down 21% in the quarter, due to the withdrawal of Z…
Read More »
January 15, 2008
Genentech
4Q Revenues: $3 billion (+9%)
4Q Earnings: $632 million (+6%)
YTD Revenues: $11.7 billion (+26%)
YTD Earnings: $2.8 billion (+31%)
Comments: U.S. product sales were up 19% to $8.5 billion for the year and $2.2 billion in the…
Read More »
December 21, 2007
BASi (Bioanalytical Systems)
4Q Revenues: $10.4 million (-3%)
4Q Loss: $203,000 (net loss of $736,000 in 4Q06)
FY07 Revenues: $45.2 million (+5%)
FY07 Earnings: $926,000 (net loss of $2.7 million in FY06)
Comments: Sales declined in 4Q…
Read More »
